Aggregator
Fruit, flies and getting frisky: how food odours trigger sexual arousal
See a tardigrade shed its skin — October’s best science images
Progress accelerates in Parkinson’s treatments
Clearing the way for a transformative stem-cell treatment for Parkinson’s disease
How the brain protects itself from Parkinson’s disease
AI agents enter the ‘wet lab’
How a once-controversial idea is advancing understanding of Parkinson’s disease
Is social media changing children’s brains? Here’s what the science says
X-ray stopwatch can measure durations of just attoseconds
The oracle of the second quadrant
AI agents run this automated biology lab that sequences DNA and more
Parkinson’s: beyond the brain
Carbon radical generation by irreversible metal-to-ligand charge transfer
Ancient DNA charts spread of Celtic and Germanic languages
A guide to Nature Index tables
Spider snooze stages
When humans disappear, biodiversity takes a surprising turn
Ecosystems depend on people: don’t abandon them
AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage
Stanford researchers have discovered an AI-identified natural molecule that dramatically suppresses appetite and promotes fat loss in animals, potentially offering an Ozempic-like weight-loss treatment without common digestive side effects or significant muscle loss. Called BRP, the molecule reduced food intake by up to 50% and targets a different brain pathway, raising hopes for a more precise obesity treatment if future human trials prove successful.
Gene editing could replace a lifetime of medication, but there's a catch
A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing lifelong medications. But scientists warn that permanently altering genes introduces risks that could take years to emerge, making long-term safety a critical challenge.